$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000150370724000005 Filed on March 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$48.75M		$205.0M
YoY Change	-1.65%		10.72%
Cost Of Revenue	$33.38M		$140.6M
YoY Change	-4.84%		2.21%
Gross Profit	$15.37M		$64.37M
YoY Change	6.07%		35.34%
Gross Profit Margin	31.53%		31.4%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.901M		$38.51M
YoY Change	-7.75%		-0.2%
% of Gross Profit	57.91%		59.83%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$12.86M		$50.03M
YoY Change	13.23%		15.6%
% of Operating Profit
Other Income/Expense, Net	$1.000M		$194.0K
YoY Change	657.58%		151.95%
Pretax Income	-$9.041M		-$151.9M
YoY Change	-10.13%		48.83%
Income Tax	$20.00K		$74.00K
% Of Pretax Income
Net Earnings	-$8.047M		-$160.2M
YoY Change	-42.51%		194.03%
Net Earnings / Revenue	-16.51%		-78.18%
Basic Earnings Per Share	-$0.04		-$0.83
Diluted Earnings Per Share	-$0.04		-$0.83
COMMON SHARES
Basic Shares Outstanding	185.7M shares	185.7M shares	189.9M shares
Diluted Shares Outstanding	185.7M shares		189.9M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$80.99M	$85.04M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$1.832M	$1.916M
YoY Change	-15.54%	-14.96%
Long-Term Investments	$124.0M	$122.9M
YoY Change	-27.72%	-30.34%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.037B	$1.059B
YoY Change	-14.84%	-14.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$913.5M	$927.7M
YoY Change	-1.73%	-0.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.594B	-$1.586B
YoY Change	10.46%	10.98%
Common Stock	$1.719B	$1.719B
YoY Change	-0.74%	-0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$125.0M	$132.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.037B	$1.059B
YoY Change	-14.84%	-14.41%

Cashflow Statement

Concept	2024 Q1	2023
OPERATING ACTIVITIES
Net Income	-$8.047M	-$160.2M
YoY Change	-42.51%	194.03%
Depreciation, Depletion And Amortization	$8.901M	$38.51M
YoY Change	-7.75%	-0.2%
Cash From Operating Activities	$927.0K	$19.06M
YoY Change	-126.22%	143.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$523.0K
YoY Change	-100.0%
Cash From Investing Activities	$8.647M	-$21.88M
YoY Change	-1157.09%	-240.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.315M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$15.34M	-$19.90M
YoY Change	217.67%	-83.23%
NET CHANGE
Cash From Operating Activities	$927.0K	$19.06M
Cash From Investing Activities	$8.647M	-$21.88M
Cash From Financing Activities	-$15.34M	-$19.90M
Net Change In Cash	-$5.763M	-$22.72M
YoY Change	-37.24%	-76.16%
FREE CASH FLOW
Cash From Operating Activities	$927.0K	$19.06M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55190
CY2023	dei	Entity Registrant Name EntityRegistrantName	NORTHSTAR HEALTHCARE INCOME, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3663988
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	16 East 34th Street,
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	18th Floor
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10016
CY2023	dei	City Area Code CityAreaCode	929
CY2023	dei	Local Phone Number LocalPhoneNumber	777-3125
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103926000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	11734000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	933002000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	122949000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	176502000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47591000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44274000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	153544000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	139841000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	3843000	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	1021000	usd
CY2023	us-gaap	Revenues Revenues	204978000	usd
CY2022	us-gaap	Revenues Revenues	185136000	usd
CY2023	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	0	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	140612000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	137578000	usd
CY2023	us-gaap	Interest Expense InterestExpense	50028000	usd
CY2022	us-gaap	Interest Expense InterestExpense	43278000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	683000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1569000	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	0	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	8058000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13817000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13938000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38511000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38587000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	45299000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	203742	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-160249000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3679000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3679000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-156570000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3364000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-153206000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	47625000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38587000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	45299000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	44842000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	18110000	usd
CY2022	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	15538000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	661826000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	26000000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	21212000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	517618000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	144000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49423000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	293074000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	288307000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	194000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7278000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1029000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11071000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21884000	usd
CY2023	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	300000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne	337000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	337000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	337000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	337000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-900000	usd
CY2023Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	day
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RealEstateInvestmentPropertyNet
CY2023Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	185712103	shares
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	85037000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	7906000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	821270000	usd
CY2023Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	142000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	11611000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1558000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2815000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1916000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2253000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	7172000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7603000	usd
CY2023Q4	us-gaap	Assets Assets	1059419000	usd
CY2022Q4	us-gaap	Assets Assets	1237835000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	898154000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	912248000	usd
CY2023Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	507000	usd
CY2022Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	993000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	27502000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	21034000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	927739000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	936763000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	195421656	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	195421656	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1857000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1954000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1716757000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1729589000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1585725000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1428840000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3679000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	132889000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	299024000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1209000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2048000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	131680000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	301072000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1059419000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1237835000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	105955000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	137322000	usd
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
CY2021	us-gaap	Revenues Revenues	243277000	usd
CY2022	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	0	usd
CY2021	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	4667000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177936000	usd
CY2021	us-gaap	Interest Expense InterestExpense	61620000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	54000	usd
CY2021	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	11105000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12691000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	323628000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-156885000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-156885000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	25067000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	189941744	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	189941744	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	194343635	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194343635	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	191629613	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	191629613	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	116712	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	66840	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3193000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-953000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3193000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-57694000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25862000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-401000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1748000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57293000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24114000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	usd
CY2021	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	10557000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165000	usd
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	724000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2552000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446818000	usd
CY2022	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	8866000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	330000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	224000	usd
CY2022	us-gaap	Dividends Dividends	97052000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3193000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	301072000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	470000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	322000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	215000	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	13399000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	404000	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-3275000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-160249000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	131680000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-160249000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8272000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38511000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49423000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3326000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3247000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3169000	usd
CY2023	us-gaap	Straight Line Rent StraightLineRent	0	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	0	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	-7803000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	697000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1120000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	637000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1662000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	226000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	207000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	165000	usd
CY2023	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	usd
CY2022	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	usd
CY2021	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	194000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-64001000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1029000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	433000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	519000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	176000	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8058000	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10557000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	22291000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-626000	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-332000	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1756000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3140000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3644000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1287000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-348000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-5928000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-985000	usd
CY2023	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-296000	usd
CY2022	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-90000	usd
CY2021	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-2680000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6629000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5222000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-17346000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-112000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-602000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-254000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19062000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7824000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6438000	usd
CY2023	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	38422000	usd
CY2022	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	29304000	usd
CY2021	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	27773000	usd
CY2023	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	136000	usd
CY2022	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	0	usd
CY2021	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	596414000	usd
CY2023	nshi	Payments For Properties Placed Into Receivership PaymentsForPropertiesPlacedIntoReceivership	994000	usd
CY2022	nshi	Payments For Properties Placed Into Receivership PaymentsForPropertiesPlacedIntoReceivership	0	usd
CY2021	nshi	Payments For Properties Placed Into Receivership PaymentsForPropertiesPlacedIntoReceivership	0	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	74376000	usd
CY2023	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	usd
CY2022	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	usd
CY2021	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	400000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	16873000	usd
CY2023	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	0	usd
CY2021	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	686000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-523000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-413000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	18492000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35000000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	48000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	8288000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	147000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	480000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	578000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1315000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	97018000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	322000	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	330000	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	724000	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	215000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	224000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2552000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19895000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-118640000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-538020000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22717000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-95278000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117368000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115660000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92943000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115660000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	38269000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	38836000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	65828000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	86000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	53000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	824000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1227000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3624000	usd
CY2023	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	13399000	usd
CY2022	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023	nshi	Right Of Use Asset Obtained In Exchange For Capital Lease Liability RightOfUseAssetObtainedInExchangeForCapitalLeaseLiability	25000	usd
CY2022	nshi	Right Of Use Asset Obtained In Exchange For Capital Lease Liability RightOfUseAssetObtainedInExchangeForCapitalLeaseLiability	0	usd
CY2021	nshi	Right Of Use Asset Obtained In Exchange For Capital Lease Liability RightOfUseAssetObtainedInExchangeForCapitalLeaseLiability	100000	usd
CY2023	nshi	Reclassification Of Assets Held For Sale Noncash ReclassificationOfAssetsHeldForSaleNoncash	11966000	usd
CY2022	nshi	Reclassification Of Assets Held For Sale Noncash ReclassificationOfAssetsHeldForSaleNoncash	0	usd
CY2021	nshi	Reclassification Of Assets Held For Sale Noncash ReclassificationOfAssetsHeldForSaleNoncash	0	usd
CY2023	nshi	Derecognition Of Operating Real Estate Placed Into Receivership Noncash Gain Loss DerecognitionOfOperatingRealEstatePlacedIntoReceivershipNoncashGainLoss	-58953000	usd
CY2022	nshi	Derecognition Of Operating Real Estate Placed Into Receivership Noncash Gain Loss DerecognitionOfOperatingRealEstatePlacedIntoReceivershipNoncashGainLoss	0	usd
CY2021	nshi	Derecognition Of Operating Real Estate Placed Into Receivership Noncash Gain Loss DerecognitionOfOperatingRealEstatePlacedIntoReceivershipNoncashGainLoss	0	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), owns a diversified portfolio of seniors housing properties, including independent living facilities (“ILF”), assisted living (“ALF”) and memory care facilities (“MCF”) located throughout the United States. In addition, the Company has an investment through a non-controlling interest in a joint venture that invests in integrated senior health campuses, which provide services associated with ILFs, ALFs, MCFs and skilled nursing facilities (“SNF”), across the Midwest region of the United States.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), which became indirect subsidiaries of the Company on June 9, 2023. NorthStar Healthcare Income Advisor, LLC invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which were collectively recorded as non-controlling interests on the accompanying consolidated balance sheets prior to June 9, 2023. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of December 31, 2023, the Company’s limited partnership interest in the Operating Partnership, directly or indirectly, was 100%.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Internalization</span></div>From inception through October 21, 2022, the Company was externally managed by CNI NSHC Advisors, LLC or its predecessor (the “Former Advisor”), an affiliate of NRF Holdco, LLC (the “Former Sponsor”). The Former Advisor was responsible for managing the Company’s operations, subject to the supervision of the Company’s board of directors, pursuant to an advisory agreement. On October 21, 2022, the Company completed the internalization of the Company’s management function (the “Internalization”). In connection with the Internalization, the Company agreed with the Former Advisor to terminate the advisory agreement and arranged for the Former Advisor to continue to provide certain services for a transition period.
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	122900000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of the COVID-19 pandemic, inflation, rising interest rates, risk of recession and other economic conditions as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material.</span></div>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	85037000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103926000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200473000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	7906000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	11734000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10465000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92943000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115660000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	200000	usd
CY2023	nshi	Finance Lease Payments FinanceLeasePayments	100000	usd
CY2022	nshi	Finance Lease Payments FinanceLeasePayments	500000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	38000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	38000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	33000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	18000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	10000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	137000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	23000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	114000	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q4	nshi	Number Of Properties Classified As Held For Sale NumberOfPropertiesClassifiedAsHeldForSale	0	property
CY2023Q4	nshi	Number Of Triple Net Lease Portfolios NumberOfTripleNetLeasePortfolios	4	property
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	118233000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	117896000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1916000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2253000	usd
CY2022	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	300000	usd
CY2021	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	1400000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	usd
CY2023Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	231000	usd
CY2023Q4	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	1916000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	500000	usd
CY2023Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	day
CY2023Q4	nshi	Number Of Triple Net Lease Portfolios NumberOfTripleNetLeasePortfolios	4	property
CY2023	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	1700000	usd
CY2022	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	1600000	usd
CY2021	us-gaap	Proceeds From Rents Received ProceedsFromRentsReceived	3400000	usd
CY2023	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	14100000	usd
CY2022	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	11200000	usd
CY2021	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	13100000	usd
CY2023	nshi	Number Of Facilities Impaired NumberOfFacilitiesImpaired	5	facility
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	248500000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1098000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2112000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4956000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-48000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-91000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	304000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1216000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2145000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5102000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	119000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-59000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	656000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	586000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15827000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14681000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16483000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15267000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16483000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15267000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-3300000	usd
CY2023Q4	us-gaap	Land Land	115758000	usd
CY2022Q4	us-gaap	Land Land	121518000	usd
CY2023Q4	us-gaap	Land Improvements LandImprovements	12705000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	18945000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	861452000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	957924000	usd
CY2023Q4	us-gaap	Tenant Improvements TenantImprovements	372000	usd
CY2022Q4	us-gaap	Tenant Improvements TenantImprovements	372000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5493000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	6736000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	93373000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	91058000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1089153000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1196553000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	267883000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	263551000	usd
CY2023Q4	us-gaap	Real Estate Investments RealEstateInvestments	821270000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	933002000	usd
CY2023	us-gaap	Depreciation Depreciation	38200000	usd
CY2022	us-gaap	Depreciation Depreciation	38300000	usd
CY2021	us-gaap	Depreciation Depreciation	53500000	usd
CY2023Q4	nshi	Number Of Properties Held For Sale NumberOfPropertiesHeldForSale	1	property
CY2023	nshi	Derecognition Of Operating Real Estate Placed Into Receivership Noncash Gain Loss DerecognitionOfOperatingRealEstatePlacedIntoReceivershipNoncashGainLoss	-59000000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	11192000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	11472000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	11759000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	12053000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	12354000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	9438000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	68268000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	122949000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	176502000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8272000	usd
CY2023	nshi	Proceeds From Equity Method Investment Distribution Operating And Investing Activities ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities	27513000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	47625000	usd
CY2022	nshi	Proceeds From Equity Method Investment Distribution Operating And Investing Activities ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities	67133000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	usd
CY2021	nshi	Proceeds From Equity Method Investment Distribution Operating And Investing Activities ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities	18110000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	128574000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	667741000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	45151000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	62396000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	903862000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	226250	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	206917	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	230083	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	240000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	211250	usd
CY2022Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.50
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	97000000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	9700000	shares
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3400000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-400000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1700000	usd
CY2023Q4	nshi	Number Of Properties Classified As Held For Sale NumberOfPropertiesClassifiedAsHeldForSale	1	property
CY2022Q4	nshi	Number Of Properties Classified As Held For Sale NumberOfPropertiesClassifiedAsHeldForSale	0	property
CY2021Q4	nshi	Number Of Properties Classified As Held For Sale NumberOfPropertiesClassifiedAsHeldForSale	0	property
CY2023	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	204978000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	140612000	usd
CY2023	us-gaap	Gross Profit GrossProfit	64366000	usd
CY2023	us-gaap	Interest Expense InterestExpense	50028000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	683000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13817000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38511000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	49423000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	194000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-64001000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8272000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-160249000	usd
CY2022	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	185136000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	137578000	usd
CY2022	us-gaap	Gross Profit GrossProfit	47558000	usd
CY2022	us-gaap	Interest Expense InterestExpense	43278000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1569000	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	8058000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13938000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38587000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	45299000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1029000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	47625000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2021	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	243277000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177936000	usd
CY2021	us-gaap	Gross Profit GrossProfit	65341000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	4667000	usd
CY2021	us-gaap	Interest Expense InterestExpense	61620000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	54000	usd
CY2021	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	11105000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12691000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7278000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2023Q4	us-gaap	Assets Assets	1059419000	usd
CY2022Q4	us-gaap	Assets Assets	1237835000	usd
CY2023	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	38422000	usd
CY2022	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	29304000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	600000	usd
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	903862000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	118854000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	988337000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	-6427000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	115758000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	985006000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1100764000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	267883000	usd
CY2023Q4	us-gaap	Sec Schedule Iii Real Estate Investment Property Net SECScheduleIIIRealEstateInvestmentPropertyNet	832881000	usd
CY2023Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1400000000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1196553000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1197900000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	88100000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	603082000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	39246000	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	30531000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	31397000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	44695000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	31878000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	5386000	usd
CY2023Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1103004000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1196553000	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1197900000	usd
CY2023Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	13851000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	usd
CY2023Q4	nshi	Sec Schedule Iii Real Estate Amountof Federal Income Tax Basis Over Cost Basis SECScheduleIIIRealEstateAmountofFederalIncomeTaxBasisOverCostBasis	344300000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	263551000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	225301000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	38174000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	38250000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	53476000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	31602000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	119216000	usd
CY2023Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	270123000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	263551000	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	225301000	usd
CY2023Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	2240000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	267883000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	263551000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	225301000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	usd
CY2023	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	194000	usd
CY2023	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	687000	usd
CY2023	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	0	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-18307000	usd
CY2023	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	74376000	usd
CY2023	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	0	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	0	usd
CY2021	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	698000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	248

Files In Submission

Name	View Source	Status
0001503707-24-000005-index-headers.html	Edgar Link	pending
0001503707-24-000005-index.html	Edgar Link	pending
0001503707-24-000005.txt	Edgar Link	pending
0001503707-24-000005-xbrl.zip	Edgar Link	pending
capturea.gif	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
imagea.jpg	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_12a.jpg	Edgar Link	pending
image_14a.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
image_33a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nhiclawbackpolicy2023ex97.htm	Edgar Link	pending
nshi-20231231.htm	Edgar Link	pending
nshi-20231231.xsd	Edgar Link	pending
nshi-20231231_g1.jpg	Edgar Link	pending
nshi-20231231_g2.jpg	Edgar Link	pending
nshi12312023exhibit211.htm	Edgar Link	pending
nshi12312023exhibit311.htm	Edgar Link	pending
nshi12312023exhibit312.htm	Edgar Link	pending
nshi12312023exhibit321.htm	Edgar Link	pending
nshi12312023exhibit322.htm	Edgar Link	pending
pg1a.jpg	Edgar Link	pending
pg2a.jpg	Edgar Link	pending
pg37.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
nshi-20231231_def.xml	Edgar Link	unprocessable
nshi-20231231_lab.xml	Edgar Link	unprocessable
nshi-20231231_pre.xml	Edgar Link	unprocessable
nshi-20231231_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trilogy-firstamendedandres.htm	Edgar Link	pending
trilogyreitholdingyear-end.htm	Edgar Link	pending
nshi-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2024 Q1 Form 10-K Financial Statement

#000150370724000005 Filed on March 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2024 Q1 Form 10-K Financial Statement

#000150370724000005 Filed on March 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs